FDA Approved: TEMOZOLOMIDE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved Amneal Pharmaceuticals LLC's supplemental application for temozolomide, a generic version of Temodar, under ANDA 203691.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma Multiforme

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

SUPPL AP for TEMOZOLOMIDE (TEMOZOLOMIDE)